The present invention relates to a composition for and a method of treating hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, hepatitis D virus (HDV) infection or a proliferative disorder in a patient using an effective amount of a compound selected from the group consisting of formulas [I] [IV] below and mixtures of two or more thereof: ##STR00001## wherein the substituents are as defined herein. Pharmaceutical compositions comprising these compounds in combination with other HBV, HCV, or HDV agents is also disclosed.

 
Web www.patentalert.com

< Quinoline derivatives process of synthesis and medicaments containing these derivatives

< Polynucleotides encoding novel human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1

> Process for manufacturing a soy protein concentrate having high isoflavone content

> Coupled polymerase chain reaction-restriction-endonuclease digestion-ligase detection reaction process

~ 00284